Why the study?
Although COPD is associated with higher cardiovascular risk, especially after exacerbations, cardiopulmonary and mortality risk stratification remains heterogeneous in clinical practice.
Does a multidisciplinary evaluation, stratification, and management strategy (including triple inhaled therapy and early post-exacerbation rehabilitation) reduce major adverse cardiovascular events and mortality in adult patients with COPD in Colombia?
Does a multidisciplinary evaluation, stratification, and management strategy (including triple inhaled therapy and early post-exacerbation rehabilitation) reduce major adverse cardiovascular events and mortality in adult patients with COPD in Colombia?
This Colombian multidisciplinary consensus establishes an evidence-based framework for stratifying and managing heightened cardiovascular risk in COPD patients, particularly emphasizing close surveillance and targeted interventions during the vulnerable 90-day post-exacerbation period.
Answers are grounded in this paper and cite their sources.
Supports closer cardiopulmonary monitoring within 30 days post-COPD exacerbation; extends evidence for integrated risk stratification in guidelines.
Introduction: Chronic obstructive pulmonary disease (COPD) is associated with higher cardiovascular risk, especially after exacerbations. However, cardiopulmonary and mortality risk stratification continues to be heterogeneous in clinical practice. Objective: To develop evidence-based guidelines, adapted to the Colombian healthcare system, for providing multidisciplinary evaluation, stratification, and management of cardiopulmonary risk in COPD patients. Methods: The Colombian Association of Pulmonology and Thoracic Surgery and the Colombian Society of Cardiology and Cardiovascular Surgery convened a multidisciplinary panel of 19 experts. Six questions were posed, and systematic literature reviews were conducted. The certainty of the evidence was evaluated with GRADE, and the recommendations were developed using an Evidence-to-Decision framework. A modified Delphi process was applied, along with formal voting using a nine-point Likert scale; ≥ 70% agreement was required to approve each recommendation. Results: The consensus developed recommendations for identifying high-risk subgroups, determining the prognostic value of exacerbations, and integrating clinical and functional variables with a selective use of biomarkers. It included considerations for pharmacological and nonpharmacological treatment, emphasizing cardiovascular safety, and also recommended targeted cardiovascular disease evaluation in the event of disproportionate symptoms, as well as tailored follow-up according to the individual risk profile. Conclusion: This consensus provides an evidence-based framework for evaluating and stratifying cardiopulmonary risk in COPD patients in Colombia, emphasizing early high-risk detection and comprehensive multidisciplinary treatment.
No takes yet. Share an insight, caveat, or question.
García-Morales et al. (2026) studied Chronic obstructive pulmonary disease (COPD) with cardiopulmonary risk. Multidisciplinary cardiopulmonary risk evaluation, stratification, and management consensus recommendations (including triple inhaled therapy LAMA/LABA/ICS, long-acting bronchodilators, pulmonary rehabilitation, and NT-proBNP screening) vs. Standard heterogeneous clinical practice or dual bronchodilator therapy (LABA/LAMA) was evaluated on Consensus approval of evidence-based recommendations (requiring >= 70% panel agreement on a 9-point Likert scale) for cardiopulmonary and mortality risk stratification and management in COPD. A multidisciplinary panel of 19 experts established consensus recommendations for stratifying and managing cardiopulmonary risk in COPD, highlighting that triple therapy reduces cardiovascular mortality versus dual therapy.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: